Tagged Articles

medication 93 articles

Unwashed hands can affect blood sugar readings

Handling fruit before checking your blood sugar can result in too-high blood glucose level readings, according to a new report in Diabetes Care. Researchers found peeling oranges, grapes or kiwi, or even holding them in your hands, results in a residue of glucose on hands. If a finger is pricked before being washed, the glucose reading will be higher than it really is. This residue can alter glucose meter readings by as much as 10 percent. Diabetics will get a truer reading if, after pricking their fingers with a lancet, wiping away the first drop of blood and testing with ... Read More

Diabetics at greater risk for fractures

People with type 2 diabetes are at a significantly greater risk for fracture-related hospitalization, according to a large study published online in Diabetes Care. The study, which began in 1987, involved about 1,800 diabetics (including both diagnosed and undiagnosed diabetics) and 13,340 people without the disease. A total of 1,078 fracture-related hospitalizations were noted during the 20-year follow up. (The study only captured inpatient hospitalizations.) Researchers found that participants without diabetes were far less likely to be hospitalized for a bone fracture compared to diabetics. However, the fracture risk was not higher among undiagnosed diabetics. Patients on oral diabetes medications ... Read More

New social media program targets prediabetics

A new social media program designed to provide regular and aggressive support for people with prediabetes was launched this week. Called Prevent, the first-of-its-kind the program matches prediabetics into small online communities based on their age, body mass index, and location. Participants are mailed a wireless scale that transmits the participant’s weight to the online system on a daily basis. Participants not only can monitor their own progress, but also the progress of other members (shown as a percentage of body weight lost) of their online community. The 16-week program introduces a new behavior change each week, then provides support ... Read More

Novel new type 2 diabetes treatment shows promise in clinical trials

A novel new type 2 diabetes drug is showing good safety and efficacy in clinical trials, drug maker Poxel announced this week. Imeglimin is the first in a new chemical class of oral anti-diabetic agents, the glimins. The drug acts on three main target organs involved in glucose homeostatis – the liver, muscle and the pancreas – and thus has a distinct mode of action compared to existing treatments for type 2 diabetes. The drug appears best when paired with other treatments. Last year, Poxel reported good results in phase 2 results of Imeglimin as an add-on therapy with metformin ... Read More

Sanofi seeks US, Europe approval for type 2 diabetes drug

Sanofi is hoping its type 2 diabetes drug Lyxumia will win approval from drug regulators in the United States and Europe and be seen as a leading contender in the heavily populated diabetes drug market. Lyxumia is in a new class of diabetes medications called GLP-1 analogues. Drugs in this class work by propting the body to release insulin when a patient’s blood sugar level climbs too high. Previously approved drugs in this class include the brand names Byetta and Victoza. Sanofi presented data on Lyxumia from late-stage studies recently at the European Association for the Study of Diabetes congress ... Read More

FDA to review drugs in new class of type 2 diabetes medications

Two type 2 diabetes drugs in a new class of blood sugar lowering medications known as SGLT2 inhibitors are hoping to win approval from the Food and Drug Administration (FDA) – Johnson & Johnson’s canagliflozin, and empagliflozin, made jointly by Eli Lilly and Boehringer Ingelheim. The drug makers presented the benefits of their medications recently at the European Association for the Study of Diabetes meeting in Berlin. The two drugs are among several of their kind for the treatment of diabetes, and are in various stages of development. The FDA is currently reviewing data for canagliflozin, and it is expected ... Read More

Singer Andy Williams dies from bladder cancer

Singer Andy Williams passed away last week after a brief battle with bladder cancer. He was 84. Williams’ career began at the young age of 8, when he debuted professionally with his brothers as the Williams Brothers Quartet. The group was a regular on local radio stations, which is where they were soon discovered by Bing Crosby, who helped them make their first professional recording, Swinging on a Star. After the quartet separated in 1951, Williams moved to New York and became a regular on the Tonight Show with Steve Allen. He landed his own show a decade later. The ... Read More

Patients with history of bladder cancer should avoid Actos altogether

Researchers have confirmed a link between a popular class of type 2 diabetes drugs and bladder cancer, Renal & Urology News reports. The drugs are in a class known as thiazolidinediones, which include the brand-name medications Avandia (rosiglitazone) and Actos (pioglitazone). The risk is even greater in patients who use Actos. “Consequently, pioglitazone (Actos) should be avoided in selected high-risk patients,” the medical publication warns. The findings come from a meta-analysis, published in the Canadian Medical Association Journal, aimed at determining the risk of bladder cancer among adults with type 2 diabetes taking this class of diabetes drugs. Type 2 ... Read More

New generic Lexapro has same risk profile as brand-name drug

Lupin Pharmaceuticals announced it has received approval from the Food and Drug Administration (FDA) to market Escitalopram Tablets (Escitalopram oxalate), a generic version of the antidepressant Lexapro. The medication is indicated for the treatment of major depressive disorder in adults and adolescents aged 12-17 years. It is also used to treat general anxiety disorder in adults. Lexapro, and its generic Escitalopram, are in a class of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs. They are among the most prescribed medications in the United States. Brand-name Lexapro generated approximately $2.7 billion in sales for the year ending June 2012. ... Read More

High blood sugar in non-diabetics linked to cognitive decline

Controlling blood sugar levels in could boost memory and emotional processing in non-diabetics, according to a new study published in the journal Neurology. The Australian study involved nearly 250 non-diabetic men and women, and found those with high blood sugar levels tended to have shrinking in specific areas of the brain. Researchers say the results remained consistent even after considerations were made for lifestyle factors such as smoking and weight. Previous research has already linked diabetes to age-related cognitive decline. Diabetes is a condition in which blood sugar levels are abnormally high. Almost all patients with the disease rely on ... Read More